NCT03527316View on ClinicalTrials.gov

Effect of Methylenedioxymethamphetamine (MDMA) (Serotonin Release) on Fear Extinction

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 18, 2019

Primary Completion Date

December 10, 2020

Study Completion Date

December 24, 2020

Conditions
Healthy
Interventions
DRUG

MDMA

125 mg MDMA per os, single dose

DRUG

Placebo

Capsules containing mannitol looking identical to the other drugs.

Trial Locations (1)

4056

Clinical Pharmacology & Toxicology, University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03527316 - Effect of Methylenedioxymethamphetamine (MDMA) (Serotonin Release) on Fear Extinction | Biotech Hunter | Biotech Hunter